Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaccinex Inc (NQ: VCNX ) 5.420 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vaccinex Inc < Previous 1 2 3 4 5 6 Next > VCNX Stock Earnings: Vaccinex Reported Results for Q2 2024 August 14, 2024 Vaccinex just reported results for the second quarter of 2024. Via InvestorPlace Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership August 14, 2024 Company reviews goals and significance of the study and outlines development strategy in Mild Cognitive Impairment due to Alzheimer’s disease From Vaccinex, Inc. Via GlobeNewswire Around $3M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying August 02, 2024 Via Benzinga Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket August 02, 2024 Via Benzinga VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024 May 16, 2024 Vaccinex just reported results for the first quarter of 2024. Via InvestorPlace VCNX Stock Earnings: Vaccinex Reported Results for Q4 2023 April 02, 2024 Vaccinex just reported results for the fourth quarter of 2023. Via InvestorPlace Why Vaccinex (VCNX) Stock Is Trading Lower February 15, 2024 Vaccinex shares are trading lower by 7.1%Thursday morning. The company announced a 1-for-14 reverse stock split. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday August 02, 2024 It's time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning! Via InvestorPlace Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease July 31, 2024 From Vaccinex, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday July 29, 2024 Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning! Via InvestorPlace Why Vaccinex (VCNX) Stock Is Popping Off February 07, 2024 Vaccinex shares are trading higher by 15% during Wednesday's session. The company announced a private placement transaction priced at $3.7 million. Via Benzinga Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024 July 17, 2024 Pepinemab is believed to block astrocyte reactivity, a key pathology driving Alzheimer’s progression From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease June 06, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 27, 2024 Via Benzinga Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session May 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 25, 2024 Via Benzinga Vaccinex Reports 2023 Financial Results and Provides Corporate Update April 02, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules March 27, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology February 21, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex, Inc. Announces Reverse Stock Split February 15, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session February 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session February 09, 2024 Via Benzinga Vaccinex Announces Pricing of $3.7 Million PIPE Financing February 07, 2024 From Vaccinex, Inc. Via GlobeNewswire Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule December 04, 2023 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 13, 2023 From Vaccinex, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.